Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   classic galactosemia
  

Disease ID 1086
Disease classic galactosemia
Definition
An inherited metabolic disorder characterized by increased levels of galactose in the blood. Clinical signs include failure to thrive, developmental delays, liver damage and jaundice, cataract, and ovarian failure.
Synonym
classic galactosemias
classical galactosaemia
classical galactosemia
classical galactosemia (disorder)
defic dis galactose 1 phosphate uridyl transferase
deficiencies, galactose-1-phosphate uridyltransferase
deficiencies, galactose-1-phosphate uridylyltransferase
deficiencies, galt
deficiency disease, galactose 1 phosphate uridyl transferase
deficiency disease, galactose-1-phosphate uridyl-transferase
deficiency galactosemia, epimerase
deficiency galactosemias, epimerase
deficiency of galactose-1-phosphate uridyl transferase
deficiency of galactose-1-phosphate uridylyltransferase
deficiency of hexose-1-phosphate uridylyltransferase
deficiency of udpglucose-hexose-1-phosphate uridylyltransferase
deficiency of udpglucose-hexose-1-phosphate uridylyltransferase (disorder)
deficiency of uridine diphosphate-glucose-hexose-1-phosphate uridylyltransferase
deficiency of uridine diphosphate-glucose-hexose-1-phosphate uridylyltransferase (disorder)
deficiency of uridine triphosphate-hexose-1-phosphate uridylyltransferase
deficiency of uridine triphosphate-hexose-1-phosphate uridylyltransferase (disorder)
deficiency of uridyl transferase
deficiency of utp-hexose-1-phosphate uridylyltransferase
deficiency of utp-hexose-1-phosphate uridylyltransferase (disorder)
deficiency, galactose-1-phosphate uridyltransferase
deficiency, galactose-1-phosphate uridylyltransferase
deficiency, galt
epimerase deficiency galactosemia
epimerase deficiency galactosemias
galactose 1 phosphate uridyl transferase defic dis
galactose 1 phosphate uridyl transferase deficiency disease
galactose 1 phosphate uridyltransferase deficiency
galactose 1 phosphate uridylyl transferase deficiency
galactose 1 phosphate uridylyltransferase deficiency
galactose phosphate uridyl transferase defic dis 01
galactose-1-phosphate uridyl transferase deficiency
galactose-1-phosphate uridyl-transferase deficiency disease
galactose-1-phosphate uridyltransferase deficiencies
galactose-1-phosphate uridyltransferase deficiency
galactose-1-phosphate uridylyltransferase deficiencies
galactose-1-phosphate uridylyltransferase deficiency
galactosemia, classic
galactosemia, epimerase deficiency
galactosemias, classic
galactosemias, epimerase deficiency
galt
galt deficiencies
galt deficiency
transferase deficiency galactosaemia
transferase deficiency galactosemia
udpglucose hexose 1 phosphate uridylyltransferase deficiency
udpglucose hexose-1-phosphate uridylyltransferase deficiency
uridyl transferase deficiency
uridyltransferase deficiencies, galactose-1-phosphate
uridyltransferase deficiency, galactose-1-phosphate
uridylyltransferase deficiencies, galactose-1-phosphate
uridylyltransferase deficiency, galactose-1-phosphate
utp hexose 1 phosphate uridylyltransferase deficiency
utp hexose 1 phosphate uridylyltransferase deficiency disease
utp hexose-1-phosphate uridylyltransferase deficiency
utp-hexose-1-phosphate uridyltransferase deficiency
utp-hexose-1-phosphate uridylyltransferase deficiency
utp-hexose-1-phosphate uridylyltransferase deficiency disease
utphexose 1 phosphate uridylyltransferase defic
Orphanet
OMIM
UMLS
C0268151
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:13)
C0016952  |  galactosemia  |  5
C0268151  |  classic galactosemia  |  2
C0030920  |  peptic ulcers  |  2
C0030920  |  peptic ulcer  |  2
C0013421  |  dystonia  |  1
C0016719  |  friedreich ataxia  |  1
C0037822  |  speech disorders  |  1
C0013720  |  ehlers-danlos syndrome  |  1
C0030920  |  peptic ulcer disease  |  1
C0086543  |  cataracts  |  1
C0017152  |  gastritis  |  1
C0004134  |  ataxia  |  1
C0003864  |  arthritis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
2592  |  GALT  |  CLINVAR;ORPHANET;UNIPROT
Inferring Gene(Waiting for update.)
Text Mined Gene(Waiting for update.)
Locus
Symbol | Locus(Total Locus:1)
GALT  |  9p13.3
Disease ID 1086
Disease classic galactosemia
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:24)
HP:0000518  |  Cataract
HP:0001824  |  Weight loss
HP:0100806  |  Sepsis
HP:0001260  |  Dysarthria
HP:0001251  |  Ataxia
HP:0009088  |  Speech articulation difficulties
HP:0001254  |  Lethargy
HP:0001943  |  Hypoglycemia
HP:0002017  |  Nausea and vomiting
HP:0000952  |  Jaundice
HP:0011968  |  Feeding difficulties
HP:0001288  |  Gait disturbance
HP:0001399  |  Hepatic failure
HP:0100022  |  Abnormality of movement
HP:0000868  |  Decreased fertility in females
HP:0000939  |  Osteoporosis
HP:0004915  |  Impairment of galactose metabolism
HP:0001508  |  Failure to thrive
HP:0001249  |  Intellectual disability
HP:0001892  |  Abnormal bleeding
HP:0000137  |  Abnormality of the ovary
HP:0011098  |  Speech apraxia
HP:0001337  |  Tremor
HP:0003811  |  Neonatal death
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:10)
HP:0004398  |  Peptic ulcer  |  2
HP:0000518  |  Cataract  |  1
HP:0001251  |  Ataxia  |  1
HP:0001337  |  Tremor  |  1
HP:0001369  |  Arthritis  |  1
HP:0001332  |  Dystonia  |  1
HP:0004349  |  Reduced bone mineral density  |  1
HP:0005263  |  Gastritis  |  1
HP:0002167  |  Speech disorder  |  1
HP:0002719  |  infections, recurrent  |  1
Disease ID 1086
Disease classic galactosemia
Manually Symptom
UMLS  | Name(Total Manually Symptoms:1)
C0003635  |  dyspraxia
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:242)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs111033634NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646745CTT
rs111033635NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646771AG
rs111033636NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646786GA,C,T
rs111033637NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646731GC
rs111033638NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646722C-
rs111033639NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646705AG
rs111033640NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646586GTCA-
rs111033643NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647097CA
rs111033644NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647101TA
rs111033645NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647113CT
rs111033646NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647119AC
rs111033647NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647136GA,T
rs111033648NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647158GA,T
rs111033649NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647166CT
rs111033651NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647140CAGCT-
rs111033652NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647140CT
rs111033654NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647169GT
rs111033655NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647213CCCTCTCA-
rs111033656NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647203CA,T
rs111033658NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647205CT
rs111033659NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647226-G
rs111033660NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647253GA
rs111033661NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647490AG
rs111033662NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647226CT-
rs111033663NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647227TC,G
rs111033664NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647244CT
rs111033665NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647247GA,C
rs111033666NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647504TC,G
rs111033667NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647655AC
rs111033668NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647524TC,G
rs111033669NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647529AG
rs111033670NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647531GA,C
rs111033673NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647682AC
rs111033674NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647695CG,T
rs111033675NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647696GA
rs111033676NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647661-A
rs111033677NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647665GA
rs111033678NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647669AC,T
rs111033679NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647678TC
rs111033680NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647702TC
rs111033681NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647706GA,T
rs111033682NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647833AG
rs111033683NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647840TC
rs111033684NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647846TG
rs111033686NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647867CT
rs111033686178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934647867CT
rs111033687NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647870TC
rs111033688NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647848CT
rs111033689NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647854T-
rs111033690178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934647858CG,T
rs111033690256148702592GALTumls:C0268151UNIPROTWhereas classic galactosemia has been hypothesized to result from GALT misfolding, a thorough functional-structural characterization of GALT most prevalent variants was still lacking, hampering the development of alternative therapeutic approaches.0.3752007452014GALT934647858CG,T
rs111033690115928232592GALTumls:C0268151BeFreeThis mutation was common in black patients with galactosemia and homozygotes (S135L/S135L) had no GALT activity or protein in their erythrocytes or lymphoblasts.0.3752007452001GALT934647858CG,T
rs11103369085514262592GALTumls:C0268151BeFreeThe S135L mutation in the GALT gene is a prevalent cause of galactosemia among black patients.0.3752007451996GALT934647858CG,T
rs111033690158414852592GALTumls:C0268151UNIPROTClassical galactosemia is an autosomal recessive disorder of galactose metabolism due to galactose-1-phosphate uridyltransferase (GALT) deficiency.0.3752007452005GALT934647858CG,T
rs111033690NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647858CG,T
rs111033692NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647878AG
rs111033693NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647896CG,T
rs111033694NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647897GA
rs111033695NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647879TA,C
rs111033697NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647882CT
rs111033699NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647902GC
rs111033700NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647936TC
rs111033701NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647906TC
rs111033702NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647914TC,G
rs111033704NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647916GA
rs111033705NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647944CT
rs111033708NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647953TC
rs111033709NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647959CA
rs111033710NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647963TC
rs111033714NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648110GC
rs111033715NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648119TC
rs111033716NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648157CG
rs111033717NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648159CA
rs111033718NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648131GA
rs111033719NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648135-G
rs111033720NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648143GA
rs111033721NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648154CA
rs111033722NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648161CA,T
rs111033723NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648172GA
rs111033725NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648163CT
rs111033726NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648349TC
rs111033728178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934648353TC
rs111033728NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648353TC
rs111033729NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648363TG
rs111033730NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648364GA
rs111033731NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648332AG
rs111033734NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648344GA
rs111033735NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648371GA
rs111033736NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648376GA
rs111033737NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648379CT
rs111033738NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648367C-
rs111033739NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648370CT
rs111033740NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648380GA,C,T
rs111033741NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648419TC
rs111033742NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648421C-
rs111033743NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648388CT
rs111033744178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934648395AC,G
rs111033744NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648395AC,G
rs111033746NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648403CT
rs111033747NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648427GA
rs111033748NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648458TC
rs111033749NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648765CT
rs111033750NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648436CA,T
rs111033751NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648445CG
rs111033752NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648446TC
rs111033753NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648456GT
rs111033754NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648766GA
rs111033755NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648826AC,G
rs111033757NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648819TC
rs111033758NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648821GA
rs111033759NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648822CA
rs111033761NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648851GA
rs111033762NA2592GALTumls:C0268151CLINVARNA0.375200745NANA934648852CATGTGCGGCGG-,ATGTGCGGCGG
rs111033763NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648859GC
rs111033764NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648867CG
rs111033765NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648886AG
rs111033766NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648888CG,T
rs111033767NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648996AG
rs111033769NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648830GT
rs111033770NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648842GCC-
rs111033772NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649021CG
rs111033773178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934649032GT
rs111033773NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649032GT
rs111033774NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649042CT
rs111033775NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649043TG
rs111033777NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649001T-
rs111033778NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649010TA,C
rs111033779NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649013TG
rs111033780NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649048GA
rs111033781102201542592GALTumls:C0268151BeFreeIdentification of mutations in the galactose-1-phosphate uridyltransferase (GALT) gene in 16 Turkish patients with galactosemia, including a novel mutation of F294Y. Mutation in brief no. 235. Online.0.3752007451999GALT934649058TA
rs111033781NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649058TA
rs111033782NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649059T-
rs111033783NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649060CA
rs111033784NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649427GA
rs111033785NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649454C-
rs111033786NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649455AG
rs111033787NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649456GT
rs111033788NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649457C-
rs111033790NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649452GA
rs111033791NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649453GA
rs111033792NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649462CA,T
rs111033794NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649479CT
rs111033795NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649463GA
rs111033796NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649472TC,G
rs111033798NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649475CT
rs111033799NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649481C-
rs111033800NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649502CG,T
rs11103380075502292592GALTumls:C0268151BeFreeWe characterized two novel mutations of the galactose-1-phosphate uridyltransferase (GALT) gene in two Japanese patients with GALT deficiency and identified N314D and R333W mutations, previously found in Caucasians.0.3752007451995GALT934649502CG,T
rs111033801NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649484C-
rs111033802NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649488GA
rs111033803NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649491CT
rs111033804NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649494CT
rs111033806NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649523GA,T
rs111033808NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649503GA,T
rs111033809NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649506AG
rs111033810NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649511AG,T
rs111033811NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649519CG
rs111033812NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649529CA
rs111033813NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649556C-
rs111033814NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649535CA
rs111033815NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649539CA
rs111033816NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649552C-
rs111033817NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649553AG
rs111033818NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649562CG,T
rs111033819NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650441AG
rs111033821NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649620CT
rs111033822NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650407CA
rs111033823NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650417CT
rs111033824NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650447TC
rs111033825NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648427-G
rs111033826NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648160CT
rs111033827NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650449AC
rs111033828NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648148TG
rs111033829NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647104GA
rs111033830NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648343AG
rs111033831NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648889GA
rs111033832NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649485TC
rs111033833NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648404AC
rs111033834NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647096GC
rs111033836NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647106TA
rs111033838NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648793TAGTACTGGT-
rs111033839NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648116TA,C
rs111033841NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649049AT
rs111033843NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648771GC
rs111033844NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648146GA,T
rs111033845NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648844CT
rs111033846NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648449TC
rs111033848NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646729CT
rs111033849NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647569TC
rs121908047237322892582GALEumls:C0268151BeFreeComparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.0.0038001862013GALE123798188CT
rs193922247NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647209AC
rs193922248NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647839AT
rs193922250NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648457GT
rs2070074178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934649445AG
rs2070074NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649445AG
rs2070074255928172592GALTumls:C0268151UNIPROTIn silico analysis (SIFT, PolyPhen-2 and the computational analysis on the static protein structure) showed potentially damaging effects of the six new variations on the GALT protein, thus expanding the genetic spectrum of GALT variations in Italy.0.3752007452015GALT934649445AG
rs207007490124092592GALTumls:C0268151BeFreeWe conclude that the codon change N314D in cis with the base-pair transition 1721C-->T produces the LA variant of galactosemia and that this nucleotide change increases GALT activity by increasing GALT protein abundance without increasing transcription or decreasing thermal lability.0.3752007451997GALT934649445AG
rs207007475502292592GALTumls:C0268151BeFreeWe characterized two novel mutations of the galactose-1-phosphate uridyltransferase (GALT) gene in two Japanese patients with GALT deficiency and identified N314D and R333W mutations, previously found in Caucasians.0.3752007451995GALT934649445AG
rs2070074229638872592GALTumls:C0268151BeFreeThe functionally neutral N314D variation in the GALT gene is associated with Duarte galactosemia and is widespread among various worldwide populations.0.3752007452012GALT934649445AG
rs2070075178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934648421CG,T
rs2070075NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648421CG,T
rs367543252NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647547AG
rs367543254NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647664TC
rs367543255NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647843GA
rs367543256NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647850CA,T
rs367543257NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647950CG
rs367543258NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647956GT
rs367543259NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648149CT
rs367543262NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649034AG
rs367543263NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649031AG
rs367543264NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649086GA
rs367543265NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649425CA
rs367543266NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649466CT
rs367543267NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649473AG
rs367543268NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650368GA
rs367543269NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647853-CC
rs367543270NA2592GALTumls:C0268151CLINVARNA0.375200745NANANANANANA
rs367543271NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649082GA,T
rs367543272NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649464CT
rs368166217NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648846CT
rs397515628NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647864-T
rs397515629NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650381C-
rs398123179NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647528AAC-
rs398123181NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648114GC
rs398123183NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648334GTATGGGCCAGCAG-
rs398123184NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648337TC
rs398123185NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648760AC
rs398123187NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649408AG
rs398123188NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649490TC
rs515726228NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650387GCACTTNNNNNNNNNNNNNNNNNNNN
rs749047676NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT;IL11RA934650448GA,C
rs75391579255928172592GALTumls:C0268151UNIPROTIn silico analysis (SIFT, PolyPhen-2 and the computational analysis on the static protein structure) showed potentially damaging effects of the six new variations on the GALT protein, thus expanding the genetic spectrum of GALT variations in Italy.0.3752007452015GALT934648170AG
rs7539157992227602592GALTumls:C0268151BeFreeClassical galactosemia is caused by one common missense mutation (Q188R) and by several rare mutations in the galactose-1-phosphate uridyltransferase (GALT) gene.0.3752007451997GALT934648170AG
rs75391579NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648170AG
rs75391579156891612592GALTumls:C0268151BeFreeHomology modeling studies on human galactose-1-phosphate uridylyltransferase and on its galactosemia-related mutant Q188R provide an explanation of molecular effects of the mutation on homo- and heterodimers.0.3752007452005GALT934648170AG
rs75391579178767242592GALTumls:C0268151BeFreeSamples (n = 243) submitted for confirmatory testing for classical galactosaemia were analysed simultaneously for GALT enzyme activity and allele-specific PCR/fragment analysis for seven mutations and two polymorphisms in the GALT gene (mutations IVS2-2A>G, p.S135L, p.T138M, p.L195P, p.K285N, p.Q188R, p.Y209C; polymorphisms p.N314D, p.L218L).0.3752007452007GALT934648170AG
rs786200978NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934647899-G
rs786204763NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648849CT
rs794726876NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934646788T-
rs794726970NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649557C-
rs794726971NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934649409GA
rs794727838NA2592GALTumls:C0268151CLINVARNA0.375200745NAGALT934648341CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:8)
HP ID HP Name MP ID MP Name Annotation
HP:0003811Neonatal deathMP:0002083premature deathdeath after weaning age, but before the normal life span (Mus: after 3 weeks of age)
HP:0001508Failure to thriveMP:0013294prenatal lethality prior to heart atrial septationdeath prior to the completion of heart atrial septation (Mus: E14.5-15.5)
HP:0100022Abnormality of movementMP:0005223abnormal dorsal-ventral polarity of the somitesanomalous development or formation of the pattern of somites along the axis that runs from the front (ventral) to the back (dorsal) surface of the body
HP:0001399Hepatic failureMP:0006138congestive heart failurecardiac output is insufficient to supply blood throughout the body, resulting in the accumulation of fluid in the lungs and other body tissues; it is related mainly to salt and water retention in the tissues rather than directly to reduced blood flow; blo
HP:0001892Abnormal bleedingMP:0005606increased bleeding timegreater than the normal duration of blood flow after skin puncture; indicative of platelet and capillary function
HP:0002017Nausea and vomitingMP:0010426abnormal heart and great artery attachmentany anomaly in the in the position or pattern of the connection site of the heart to any of the great arteries, including the pulmonary artery and aorta
HP:0000868Decreased fertility in femalesMP:0001921reduced fertilitydiminished ability to produce live offspring
HP:0001824Weight lossMP:0005114premature hair lossrelease of fur at an earlier than expected time
Mapped by homologous gene(Total Items:23)
HP ID HP Name MP ID MP Name Annotation
HP:0001399Hepatic failureMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0001288Gait disturbanceMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0100022Abnormality of movementMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0000868Decreased fertility in femalesMP:0014169decreased brown adipose tissue massdecreased physical bulk or volume of brown adipose tissue
HP:0000518CataractMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0001508Failure to thriveMP:0020234decreased basal metabolismdecrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state
HP:0011968Feeding difficultiesMP:0020234decreased basal metabolismdecrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state
HP:0004915Impairment of galactose metabolismMP:0013279increased fasted circulating glucose levelincrease in the amount of glucose in the blood at some defined time point after eating compared to controls
HP:0001337TremorMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000939OsteoporosisMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
HP:0001892Abnormal bleedingMP:0020138delayed bone mineralizationlate onset of the process by which minerals are deposited into bone
HP:0001260DysarthriaMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0009088Speech articulation difficultiesMP:0011089perinatal lethality, complete penetrancedeath of all organisms of a given genotype in a population within the perinatal period (Mus: E18.5 through postnatal day 1)
HP:0002017Nausea and vomitingMP:0020220decreased tear productiondecreased production of the amount of fluid produced in the eye
HP:0000952JaundiceMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0100806SepsisMP:0011708decreased fibroblast cell migrationreduced frequency of or less rapid fibroblast cell migration that is accomplished by extension and retraction of a fibroblast pseudopodium
HP:0001824Weight lossMP:0020220decreased tear productiondecreased production of the amount of fluid produced in the eye
HP:0001943HypoglycemiaMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0001249Intellectual disabilityMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0001254LethargyMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0011098Speech apraxiaMP:0011092embryonic lethality, complete penetrancedeath of all organisms of a given genotype in a population within the embryonic period prior to organogenesis (Mus: prior to E14)
HP:0001251AtaxiaMP:0020301short tonguedecreased length of the mobile mass of muscular tissue and surrounding epithelial tissue occupying the cavity of the mouth and forming part of the floor
HP:0003811Neonatal deathMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
Disease ID 1086
Disease classic galactosemia
Case(Waiting for update.)